| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |